Halloween Special Affielisa® Human Hla Class I Histocompatibility Antigen, A-31 Alpha Chain Elisa [ Hla-a] Fast Dispatch [6EmL5GOk]

AffiELISA® Human HLA class I histocompatibility antigen, A-31 alpha chain ELISA [HLA-A]

The AffiELISA® Human HLA class I histocompatibility antigen, A-31 alpha chain ELISA [HLA-A] is a cutting-edge diagnostic tool designed for accurate and efficient detection of HLA-A antigens. This product offers a reliable and sensitive method for researchers and medical professionals to analyze the expression of HLA-A antigens, which are crucial in various immunological studies and clinical applications. With its exceptional performance and user-friendly design, the AffiELISA® is a preferred choice for those seeking high-quality and reliable results.

Product Properties and Specifications

The AffiELISA® utilizes a proprietary technology that ensures precise and reproducible results. This ELISA kit is designed to detect the A-31 alpha chain of the HLA class I histocompatibility antigen, providing a comprehensive analysis of HLA-A expression. Key features include:

• High Sensitivity: Detects low levels of HLA-A antigens with exceptional accuracy.
• Specificity: Minimizes cross-reactivity with other HLA antigens, ensuring reliable results.
• Easy-to-Use Protocol: A streamlined procedure that simplifies the testing process, saving time and resources.
• Comprehensive Kit: Includes all necessary reagents and instructions for a successful analysis.

Practical Uses and Benefits

The AffiELISA® Human HLA class I histocompatibility antigen, A-31 alpha chain ELISA [HLA-A] is a versatile tool with numerous applications in the field of immunology and clinical diagnostics. Its benefits include:

• Immunological Research: Facilitates the study of immune responses and the role of HLA-A antigens in various diseases.
• Transplant Medicine: Assists in identifying suitable donors for organ transplantation and monitoring graft rejection.
• Cancer Research: Provides insights into the expression of HLA-A antigens in cancer cells and their potential as therapeutic targets.